Guardant Health Stock Net Income
| GH Stock | USD 32.65 1.67 5.39% |
Guardant Health fundamentals help investors to digest information that contributes to Guardant Health's financial success or failures. It also enables traders to predict the movement of Guardant Stock. The fundamental analysis module provides a way to measure Guardant Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Guardant Health stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -479.4 M | -455.5 M | |
| Net Loss | -589.1 M | -559.7 M | |
| Net Loss | -479.4 M | -455.5 M | |
| Net Loss | (4.28) | (4.50) | |
| Net Income Per E B T | 1.00 | 0.80 |
Guardant | Net Income |
Guardant Health Company Net Income Analysis
Guardant Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Guardant Health Net Income | (479.45 M) |
Most of Guardant Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardant Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Guardant Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Guardant Health is extremely important. It helps to project a fair market value of Guardant Stock properly, considering its historical fundamentals such as Net Income. Since Guardant Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Guardant Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Guardant Health's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Guardant Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Guardant Health reported net income of (479.45 Million). This is 240.48% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 183.97% higher than that of the company.
Guardant Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardant Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardant Health could also be used in its relative valuation, which is a method of valuing Guardant Health by comparing valuation metrics of similar companies.Guardant Health is currently under evaluation in net income category among its peers.
Guardant Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Guardant Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Guardant Health's managers, analysts, and investors.Environmental | Governance | Social |
Guardant Health Institutional Holders
Institutional Holdings refers to the ownership stake in Guardant Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Guardant Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Guardant Health's value.| Shares | Geode Capital Management, Llc | 2024-09-30 | 2.8 M | Parkwood Llc | 2024-06-30 | 2.8 M | State Street Corp | 2024-06-30 | 2.8 M | Fuller & Thaler Asset Management Inc | 2024-09-30 | 2.2 M | Millennium Management Llc | 2024-06-30 | 2.1 M | Temasek Holdings Ltd. | 2024-09-30 | 2.1 M | Fidelity International Ltd | 2024-06-30 | 2.1 M | Ark Investment Management Llc | 2024-09-30 | 1.5 M | Fmr Inc | 2024-09-30 | 1.5 M | Vanguard Group Inc | 2024-09-30 | 11.7 M | Blackrock Inc | 2024-06-30 | 11.2 M |
Guardant Fundamentals
| Return On Equity | -6.09 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.61) % | ||||
| Current Valuation | 4.37 B | ||||
| Shares Outstanding | 123.56 M | ||||
| Shares Owned By Insiders | 4.56 % | ||||
| Shares Owned By Institutions | 95.44 % | ||||
| Number Of Shares Shorted | 10.26 M | ||||
| Price To Earning | (12.01) X | ||||
| Price To Book | 55.67 X | ||||
| Price To Sales | 5.83 X | ||||
| Revenue | 563.95 M | ||||
| Gross Profit | 293.21 M | ||||
| EBITDA | (433.31 M) | ||||
| Net Income | (479.45 M) | ||||
| Cash And Equivalents | 853.69 M | ||||
| Cash Per Share | 8.35 X | ||||
| Total Debt | 1.35 B | ||||
| Debt To Equity | 4.32 % | ||||
| Current Ratio | 6.18 X | ||||
| Book Value Per Share | (0.49) X | ||||
| Cash Flow From Operations | (324.98 M) | ||||
| Short Ratio | 7.41 X | ||||
| Earnings Per Share | (4.28) X | ||||
| Price To Earnings To Growth | (0.66) X | ||||
| Target Price | 43.0 | ||||
| Number Of Employees | 1.77 K | ||||
| Beta | 1.11 | ||||
| Market Capitalization | 4.03 B | ||||
| Total Asset | 1.79 B | ||||
| Retained Earnings | (2.14 B) | ||||
| Working Capital | 1.14 B | ||||
| Current Asset | 219.68 M | ||||
| Current Liabilities | 24.24 M | ||||
| Net Asset | 1.79 B |
About Guardant Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardant Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardant Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardant Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Guardant Health Piotroski F Score and Guardant Health Altman Z Score analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.